Salix Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference

Show Health and Fitness Publications

Tue, February 21, 2012

[ Tue, Feb 21st 2012 ]: Market Wire

Response Genetics Regains NASDAQ Compliance

[ Tue, Feb 21st 2012 ]: Market Wire

Horizon Pharma to Present at the Cowen and Company Health Care Conference

[ Tue, Feb 21st 2012 ]: Market Wire

Cytokinetics Announces Initiation of Phase I Clin .. tions of Omecamtiv Mecarbil in Healthy Volunteers

[ Tue, Feb 21st 2012 ]: Market Wire

China Cord Blood Corporation to Report Third Quar .. irst Nine Months of Fiscal 2012 Financial Results

[ Tue, Feb 21st 2012 ]: Market Wire

Repligen Announces FDA Grant of Priority Review for SecreFloa" NDA

[ Tue, Feb 21st 2012 ]: Market Wire

Isis Pharmaceuticals to Present at the 2012 Citi Global Health Care Conference

[ Tue, Feb 21st 2012 ]: Market Wire

Oncolytics Biotech Inc. Enters into Sponsorship A .. for Randomized Phase II Study in Prostate Cancer

[ Tue, Feb 21st 2012 ]: Market Wire

Oral Treprostinil New Drug Application Accepted by FDA for Review

[ Tue, Feb 21st 2012 ]: Market Wire

PDL BioPharma to Present at Upcoming Conferences

[ Tue, Feb 21st 2012 ]: Market Wire

Salix Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference

[ Tue, Feb 21st 2012 ]: Market Wire

Questcor Recognized by Child Neurology Foundation .. tstanding Corporate Responsibility and Leadership

[ Tue, Feb 21st 2012 ]: Market Wire

Capital Senior Living Corporation to Present at R .. al Healthcare Conference on Wednesday, February 2

[ Tue, Feb 21st 2012 ]: Market Wire

Threshold Pharmaceuticals Announces Positive Phas .. ults of TH-302 in Patients With Pancreatic Cancer

[ Tue, Feb 21st 2012 ]: Market Wire

Simcere Pharmaceutical Group to Announce Fourth Q .. 011 Financial Results on Wednesday, March 7, 2012

[ Tue, Feb 21st 2012 ]: Market Wire

GlucAffect Blood Sugar Management Formula From Reliv Earns Patent

[ Tue, Feb 21st 2012 ]: Market Wire

Inovio's Scientific Advisory Board Chairman Elect .. erican Association for the Advancement of Science

Mon, February 20, 2012

[ Mon, Feb 20th 2012 ]: Market Wire

Galapagos announces GSK decision to exercise opti .. r investigational medicines GLPG0778 and GLPG0555

[ Mon, Feb 20th 2012 ]: Market Wire

Immunotec Provides Corporate Update and Year End Financial Results

[ Mon, Feb 20th 2012 ]: Market Wire

Immunotec Announces Proposed Share Consolidation

[ Mon, Feb 20th 2012 ]: Market Wire

Kristi Ann Matus to Head Aetnaas Government Services Organization

[ Mon, Feb 20th 2012 ]: Market Wire

Cubist Pharmaceuticals to Present at February/March Investor Conferences

[ Mon, Feb 20th 2012 ]: Market Wire

Dako Enters Into an Additional Collaboration With .. ion Diagnostic Test (pharmDx(TM)) for an Investig

[ Mon, Feb 20th 2012 ]: Market Wire

Baxter to Present at the Cowen and Company 32nd Annual Healthcare Conference

[ Mon, Feb 20th 2012 ]: Market Wire

Theragenics to Report Fourth Quarter and Year-end 2011 Financial Results Thursday, February 23

[ Mon, Feb 20th 2012 ]: Market Wire

2012 Economic Outlook -- Report Highlights Boston .. ific Corporation and Varian Medical Systems, Inc.

[ Mon, Feb 20th 2012 ]: Market Wire

2012 Economic Outlook -- Report Highlights Hologic, Inc. and Mattel, Inc.

[ Mon, Feb 20th 2012 ]: Market Wire

Anvita Health Integrates Smart Problem List Inside Covisint and AT&T Healthcare Community Online

[ Mon, Feb 20th 2012 ]: Market Wire

Pfizer and GlaxoSmithKline Look to Curb Costs as Generic Competition Cuts Into Revenues

[ Mon, Feb 20th 2012 ]: Market Wire

Pharmaceutical Employees Fearful of Losing Jobs as Patent Cliffs Loom

[ Mon, Feb 20th 2012 ]: Market Wire

WellCare Health Plans Implements MedAssurant's Star Advantagea" Solution

[ Mon, Feb 20th 2012 ]: Market Wire

PAREXEL International to Present at Citi Global Healthcare Conference

Sat, February 18, 2012

[ Sat, Feb 18th 2012 ]: Market Wire

Bull amp;; Lifshitz, LLP Announces Investigation of SeraCare Life Sciences, Inc.

[ Sat, Feb 18th 2012 ]: Market Wire

Bull & Lifshitz, LLP Announces Investigation of SeraCare Life Sciences, Inc.

Fri, February 17, 2012

[ Fri, Feb 17th 2012 ]: Market Wire

En Turquie, le TheraSphere redonne espoir aux patients atteints de cancer du foie

[ Fri, Feb 17th 2012 ]: Market Wire

Pfizer And Hisun Announce Progress On Potential J .. Access To High Quality Branded Generic Medicines

[ Fri, Feb 17th 2012 ]: Market Wire

Endo Pharmaceuticals to Present at J.P. Morgan An .. h Yield amp;; Leveraged Finance Conference

[ Fri, Feb 17th 2012 ]: Market Wire

Endo Pharmaceuticals to Present at J.P. Morgan An .. Global High Yield & Leveraged Finance Conference

[ Fri, Feb 17th 2012 ]: Market Wire

Par Pharmaceutical Completes Acquisition of Edict Pharmaceuticals

[ Fri, Feb 17th 2012 ]: Market Wire

Codexis Appoints Interim Chief Executive Officer

[ Fri, Feb 17th 2012 ]: Market Wire

Savient Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference

[ Fri, Feb 17th 2012 ]: Market Wire

Medtronic Resolute Integrity Drug-Eluting Stent O .. FDA Approval for Treating Coronary Artery Disease

[ Fri, Feb 17th 2012 ]: Market Wire

3 Reasons to Fall in Love with Soy For American Heart Month

[ Fri, Feb 17th 2012 ]: Market Wire

Greatbatch Announces the Acquisition of NeuroNexus

[ Fri, Feb 17th 2012 ]: Market Wire

ProMetic Improves its Short Term Liquidity by $5.0 Million

[ Fri, Feb 17th 2012 ]: Market Wire

Gilead comunica i dati relativi ai pazienti affet .. con risposta nulla iscritti allo studio ELECTRON

[ Fri, Feb 17th 2012 ]: Market Wire

Gilead anuncia datos de los pacientes con hepatit .. lo de genotipo 1 inscritos en el estudio ELECTRON

[ Fri, Feb 17th 2012 ]: Market Wire

TheraSphere proporciona esperanza para los pacientes con cncer de hgado de Turqua

[ Fri, Feb 17th 2012 ]: Market Wire

Gilead verffentlicht Daten fr die an der ELECTRON .. is-C-Patienten mit Genotyp 1, die als Nullrespond

Salix Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference

//health-fitness.news-articles.net/content/2012/ .. t-rbc-capital-markets-healthcare-conference.html

Published in Health and Fitness on Tuesday, February 21st 2012 at 4:20 GMT by Market Wire
^{🞛 This publication is a summary or evaluation of another publication}

RALEIGH, N.C.--([ BUSINESS WIRE ])--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at the 2012 RBC Capital Markets Healthcare Conference in New York, NY on Tuesday, February 28, 2012 at 2:35 p.m. ET.

Interested parties can access a live audio web cast of the presentation at [ http://www.salix.com ]. A replay of the presentation will be available at the same location.

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salixas strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Companyas gastroenterology specialty sales and marketing team.

Salix trades on the NASDAQ Global Select Market under the ticker symbol aSLXPa.

For more information, please visit our Website at [ www.salix.com ] or contact the Company at 919-862-1000. Follow us on Twitter (@SalixPharma) and Facebook ([ www.facebook.com/SalixPharma ]). Information on our web site is not incorporated in our SEC filings.